Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Lab Invest. 2010 Mar 15;90(5):665–673. doi: 10.1038/labinvest.2010.51

Figure 1.

Figure 1

Histology and immunohistochemistry of matched primary tumor and corresponding xenograft for case 1. Hematoxylin and eosin (HE) and immunohistochemical labeling for cytokeratin, MUC1, MUC2, P16/cdkn2a, TP53, and DPC4/SMAD4. Negative region of P16/cdkn2a is shown for the primary tumor, however the staining is heterogeneous as shown in supplemental figure 2. Magnification as indicated.